Analabs quoted securities in Maybank stands at RM21.57mil


KUALA LUMPUR: Analabs Resources Bhd has acquired quoted securities in Malayan Banking Bhd (Maybank) between December 21, 2022, and today, amounting to RM21.57 million.

In a filing with Bursa Malaysia today, the chemicals trading outfit said the aggregate of the purchase consideration has exceeded 5.0 per cent of the Analabs Group’s audited consolidated net assets as at April 30, 2022.

"The shares were purchased in the open market at prevailing prices as quoted on the Bursa Malaysia Securities Bhd and funded by the group’s share margin account.

"The acquisition was carried out with the intention of deriving dividend income and for potential capital gains,” Analabs said. - Bernama

Analabs , Maybank , acquisition , Bursa Malaysia

   

Next In Business News

Gold drops nearly 2% on profit-booking, Trump's Treasury secretary pick
Bonds bounce, dollar dips on Bessent pick
Mr DIY Indonesian business plans IPO to raise up to US$297mil
China's NEV market in a league of its own
Singapore Oct core inflation at 2.1% y/y, lowest in almost 3 years
TMK Chemicals aims to raise RM385mil from Main Market IPO
Malaysia's September LI up 1.8%, shows continued economic growth - DoSM
CBH Engineering inks underwriting deal with Mercury Securities
ACE Market-bound Topvision aims to raise RM17.89mil from public offering
FBM KLCI jumps 15 points as banks rally ahead of results

Others Also Read